While online streaming is no doubt convenient and affordable compared with physical media, many of us still prefer owning a physical object like CDs for our music collection. CDs are reliable, they're ...

Streaming and vinyl may be all the rage, but there are plenty of us who have never let go of our CD collection and enjoy listening to and buying CDs to this day. What Hi-Fi? has been testing and ...

The US buyout firm is pairing with the French pharma giant to buy out its consumer unit. Success here requires much more than cutting costs. Chris Hughes is a Bloomberg Opinion columnist covering ...

Global investment firm CD&R on Monday announced an open offer to acquire a 26 per cent stake in Sanofi Consumer Healthcare India Ltd for an aggregate of up to Rs 2,983 crore. The development follows ...

Global investment firm CD&R on Monday announced an open offer to acquire a 26% stake in Sanofi Consumer Healthcare India Ltd. for an aggregate of up to Rs 2,983 crore. The development follows Sanofi ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

French pharmaceutical group Sanofi and US private equity firm Clayton Dubilier & Rice (CD&R) have entered exclusive negotiations regarding the partial takeover of Sanofi subsidiary Opella.

The deal would allow Sanofi to focus on its more lucrative, but riskier, innovative drugs and vaccines, and CD&R to take a 50% controlling stake in a business that is home to brands such as ...

The proposed transaction would see the French pharmaceutical company sell a controlling 50% stake in Opella--home to brands such as Allegra, Dulcolax and IcyHot--to CD&R, French state-owned ...

PARIS (Reuters) -French drugmaker Sanofi said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U.S. private equity firm Clayton ...

Sanofi and CD&R enter exclusive negotiations to transfer a 50% controlling stake in Opella with Sanofi to remain a significant shareholder With 11,000 talented and passionate people bringing ...

The renewed negotiations come after CD&R agreed to pledges around local jobs, investments and production, Bloomberg reported earlier. Sanofi encountered a backlash in France when it chose the US ...